PAMU
KALA icon

Pictet Asset Management (UK)’s KALA BIO KALA Stock Holding History

Pictet Asset Management (UK)’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$2.08M Buy
+157
New +$2.47M ﹤0.01% 1005

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management (UK)'s KALA Position: Q2 2021 in Review

Pictet Asset Management (UK) opened a new position in KALA BIO (KALA) in Q2 2021: 157 shares worth $2.08M. The stake represents ﹤0.01% of the portfolio and ranks #1005 among its holdings.

97 funds tracked by Wall St. Rank hold KALA as of Q2 2021.

  • Pictet Asset Management (UK) held 157 shares of KALA BIO worth $2.08M as of Q2 2021.
  • KALA BIO was a new Pictet Asset Management (UK) position in Q2 2021.
  • KALA BIO made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1005 holding.
  • 97 funds tracked by Wall St. Rank held KALA BIO as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.